1. |
ENSGALG00000026079 |
ENSGALG00000026079 |
4 |
3 |
- |
- |
1.000 |
1.000 |
- |
1.000 |
- |
- |
- |
- |
|
2. |
KCNV2 |
ENSGALG00000010173 |
2 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
potassium voltage-gated channel modifier subfamily V member 2 [Source:HGNC Symbol;Acc:HGNC:19698] |
3. |
TINAG |
ENSGALG00000016300 |
5 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
tubulointerstitial nephritis antigen [Source:NCBI gene;Acc:421888] |
4. |
ATP6V1C2 |
ENSGALG00000016446 |
3 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
ATPase H+ transporting V1 subunit C2 [Source:HGNC Symbol;Acc:HGNC:18264] |
5. |
SOX6 |
ENSGALG00000006074 |
102 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
Gallus gallus SRY-box 6 (SOX6), mRNA. [Source:RefSeq mRNA;Acc:NM_001318451] |
6. |
GHRHR-LR |
ENSGALG00000005242 |
2 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
growth-hormone releasing hormone-like peptide receptor |
7. |
PODN |
ENSGALG00000021869 |
71 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
podocan [Source:HGNC Symbol;Acc:HGNC:23174] |
8. |
ARL6 |
ENSGALG00000019215 |
11 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
ADP ribosylation factor like GTPase 6 [Source:NCBI gene;Acc:418433] |
9. |
GALR1L |
ENSGALG00000003425 |
1 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
galanin receptor type 1-like [Source:NCBI gene;Acc:415713] |
10. |
WDR16 |
WDR16 |
22 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
|
11. |
FABP2 |
ENSGALG00000011986 |
15 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
fatty acid binding protein 2 [Source:NCBI gene;Acc:422678] |
12. |
FAM124B |
ENSGALG00000005118 |
2 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
family with sequence similarity 124 member B [Source:HGNC Symbol;Acc:HGNC:26224] |
13. |
MTMR4 |
ENSGALG00000001042 |
4 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
myotubularin related protein 4 [Source:HGNC Symbol;Acc:HGNC:7452] |
14. |
LSMEM1 |
ENSGALG00000009446 |
3 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
leucine rich single-pass membrane protein 1 [Source:HGNC Symbol;Acc:HGNC:22036] |
15. |
FOXE3 |
|
11 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
forkhead box E3 |
16. |
TSHR |
ENSGALG00000010572 |
1 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
thyroid stimulating hormone receptor [Source:NCBI gene;Acc:428900] |
17. |
H2B-I |
H2B-I |
13 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
|
18. |
C4orf45 |
ENSGALG00000045983 |
1 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
chromosome 4 open reading frame 45 [Source:HGNC Symbol;Acc:HGNC:26342] |
19. |
ENSGALG00000010336 |
ENSGALG00000010336 |
16 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
|
20. |
NOD1 |
ENSGALG00000036807 |
10 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
Gallus gallus nucleotide binding oligomerization domain containing 1 (NOD1), mRNA. [Source:RefSeq mRNA;Acc:NM_001318438] |
21. |
HEPHL1 |
ENSGALG00000043027 |
14 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
hephaestin like 1 [Source:HGNC Symbol;Acc:HGNC:30477] |
22. |
SLITRK6 |
ENSGALG00000016904 |
30 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
SLIT and NTRK like family member 6 [Source:HGNC Symbol;Acc:HGNC:23503] |
23. |
LMTK2 |
ENSGALG00000003479 |
46 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
lemur tyrosine kinase 2 [Source:HGNC Symbol;Acc:HGNC:17880] |
24. |
KRT12 |
ENSGALG00000019715 |
1 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
keratin 12 [Source:HGNC Symbol;Acc:HGNC:6414] |
25. |
CPSF4L |
ENSGALG00000004441 |
4 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
cleavage and polyadenylation specific factor 4 like, transcript variant X2 |
26. |
SLC36A4 |
ENSGALG00000017227 |
3 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
solute carrier family 36 member 4 [Source:HGNC Symbol;Acc:HGNC:19660] |
27. |
EOMES |
ENSGALG00000027247 |
27 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
Gallus gallus eomesodermin (EOMES), mRNA. [Source:RefSeq mRNA;Acc:NM_001321555] |
28. |
CR1L |
ENSGALG00000023950 |
98 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
complement C3b/C4b receptor 1 like [Source:NCBI gene;Acc:419853] |
29. |
DUSP8 |
ENSGALG00000006647 |
3 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
dual specificity phosphatase 8 [Source:HGNC Symbol;Acc:HGNC:3074] |
30. |
NPHS2 |
ENSGALG00000004163 |
850 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
NPHS2, podocin [Source:HGNC Symbol;Acc:HGNC:13394] |
31. |
SFT2D2 |
ENSGALG00000019228 |
10 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
SFT2 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:25140] |
32. |
ENSGALG00000006504 |
ENSGALG00000006504 |
3 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
|
33. |
ENSGALG00000029065 |
ENSGALG00000029065 |
2 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
|
34. |
ENSGALG00000019267 |
ENSGALG00000019267 |
11 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
|
35. |
ABCA7 |
ENSGALG00000002453 |
22 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
ATP-binding cassette, sub-family A (ABC1), member 7, transcript variant X5 |
36. |
ENSGALG00000003796 |
ENSGALG00000003796 |
7 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
|
37. |
GPR82 |
ENSGALG00000044763 |
2 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
G protein-coupled receptor 82 [Source:HGNC Symbol;Acc:HGNC:4533] |
38. |
AMMECR1 |
ENSGALG00000008074 |
5 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 [Source:HGNC Symbol;Acc:HGNC:467] |
39. |
SBSPON |
ENSGALG00000043532 |
5 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
somatomedin B and thrombospondin type 1 domain containing [Source:HGNC Symbol;Acc:HGNC:30362] |
40. |
ENSGALG00000008069 |
ENSGALG00000008069 |
2 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
|
41. |
ARL15 |
ENSGALG00000014911 |
13 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
ADP ribosylation factor like GTPase 15 [Source:HGNC Symbol;Acc:HGNC:25945] |
42. |
gga-mir-1634-2 |
gga-mir-1634-2 |
1 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
|
43. |
FADS1L1 |
ENSGALG00000020485 |
3 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
fatty acid desaturase 1-like 1 |
44. |
TMEM30C |
TMEM30C |
6 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
|
45. |
CDCP2 |
ENSGALG00000010752 |
4 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
CUB domain containing protein 2 [Source:HGNC Symbol;Acc:HGNC:27297] |
46. |
ITIH3 |
ENSGALG00000001697 |
2 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
inter-alpha-trypsin inhibitor heavy chain 3 [Source:HGNC Symbol;Acc:HGNC:6168] |
47. |
CACNA1C |
ENSGALG00000013022 |
322 |
1 |
- |
- |
- |
1.000 |
- |
- |
- |
- |
- |
- |
calcium voltage-gated channel subunit alpha1 C [Source:HGNC Symbol;Acc:HGNC:1390] |
48. |
PRPS2 |
ENSGALG00000016592 |
165 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
phosphoribosyl pyrophosphate synthetase 2 [Source:NCBI gene;Acc:418639] |
49. |
ENSGALG00000001754 |
ENSGALG00000001754 |
45 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
|
50. |
ENSGALG00000009329 |
ENSGALG00000009329 |
2 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
|
51. |
DLK1 |
ENSGALG00000011244 |
5 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
delta like non-canonical Notch ligand 1 [Source:NCBI gene;Acc:423459] |
52. |
HBE1 |
ENSGALG00000028273 |
189 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
hemoglobin subunit epsilon 1 [Source:NCBI gene;Acc:428114] |
53. |
MYO7A |
ENSGALG00000031450 |
16 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
myosin VIIA [Source:HGNC Symbol;Acc:HGNC:7606] |
54. |
ZBTB37 |
ENSGALG00000004597 |
1 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
zinc finger and BTB domain containing 37 [Source:HGNC Symbol;Acc:HGNC:28365] |
55. |
ENSGALG00000012217 |
ENSGALG00000012217 |
8 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
|
56. |
TNNI3K |
ENSGALG00000011353 |
10 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
TNNI3 interacting kinase [Source:NCBI gene;Acc:100533999] |
57. |
K60 |
K60 |
4 |
1 |
- |
- |
- |
- |
- |
1.000 |
- |
- |
- |
- |
|
58. |
SLC27A6 |
ENSGALG00000000184 |
98 |
0.995 |
- |
- |
- |
- |
- |
0.995 |
- |
- |
- |
- |
solute carrier family 27 member 6 [Source:HGNC Symbol;Acc:HGNC:11000] |
59. |
ENSGALG00000014539 |
ENSGALG00000014539 |
31 |
0.978 |
- |
- |
- |
- |
- |
0.978 |
- |
- |
- |
- |
|
60. |
MPL |
ENSGALG00000009965 |
334 |
0.974 |
- |
- |
- |
- |
- |
0.974 |
- |
- |
- |
- |
MPL proto-oncogene, thrombopoietin receptor [Source:NCBI gene;Acc:414804] |
61. |
KIAA1919 |
KIAA1919 |
58 |
0.972 |
- |
- |
0.972 |
- |
- |
- |
- |
- |
- |
- |
|
62. |
LRRK1 |
LRRK1 |
35 |
0.971 |
- |
- |
- |
- |
- |
0.971 |
- |
- |
- |
- |
|
63. |
ENSGALG00000020283 |
ENSGALG00000020283 |
10 |
0.97 |
- |
- |
- |
0.970 |
- |
- |
- |
- |
- |
- |
|
64. |
TEX2 |
ENSGALG00000003496 |
23 |
0.952 |
- |
- |
- |
- |
- |
0.952 |
- |
- |
- |
- |
testis expressed 2 [Source:HGNC Symbol;Acc:HGNC:30884] |
65. |
ITGB8 |
ENSGALG00000010875 |
13 |
0.941 |
- |
- |
- |
- |
- |
0.941 |
- |
- |
- |
- |
integrin subunit beta 8 [Source:HGNC Symbol;Acc:HGNC:6163] |
66. |
HGSNAT |
ENSGALG00000010136 |
18 |
0.941 |
- |
- |
- |
0.941 |
- |
- |
- |
- |
- |
- |
heparan-alpha-glucosaminide N-acetyltransferase [Source:HGNC Symbol;Acc:HGNC:26527] |
67. |
CRISPLD1 |
ENSGALG00000033880 |
64 |
0.933 |
- |
- |
- |
- |
- |
0.933 |
- |
- |
- |
- |
cysteine rich secretory protein LCCL domain containing 1 [Source:NCBI gene;Acc:395369] |
68. |
MAP3K19 |
ENSGALG00000028457 |
17 |
0.932 |
- |
- |
- |
- |
- |
0.932 |
- |
- |
- |
- |
mitogen-activated protein kinase kinase kinase 19 [Source:HGNC Symbol;Acc:HGNC:26249] |
69. |
DLG2 |
|
56 |
0.93 |
- |
- |
- |
- |
- |
0.930 |
- |
- |
- |
- |
discs large MAGUK scaffold protein 2, transcript variant X24 |
70. |
CYGB |
ENSGALG00000001892 |
3 |
0.93 |
- |
- |
- |
- |
- |
0.930 |
- |
- |
- |
- |
cytoglobin [Source:NCBI gene;Acc:427802] |
71. |
CLEC18B |
ENSGALG00000027183 |
284 |
0.926 |
- |
- |
- |
0.926 |
- |
- |
- |
- |
- |
- |
C-type lectin domain family 18 member B, transcript variant X2 |
72. |
R3HDML |
ENSGALG00000046204 |
145 |
0.925 |
- |
- |
- |
0.925 |
- |
- |
- |
- |
- |
- |
R3H domain containing like [Source:HGNC Symbol;Acc:HGNC:16249] |
73. |
WDR65 |
WDR65 |
26 |
0.924 |
- |
- |
- |
0.924 |
- |
- |
- |
- |
- |
- |
|
74. |
INHBA |
ENSGALG00000034616 |
49 |
0.923 |
- |
- |
- |
0.923 |
- |
- |
- |
- |
- |
- |
inhibin subunit beta A [Source:NCBI gene;Acc:396361] |
75. |
ENSGALG00000020884 |
ENSGALG00000020884 |
22 |
0.92 |
- |
- |
- |
- |
- |
0.920 |
- |
- |
- |
- |
|
76. |
PLCXD2 |
ENSGALG00000015375 |
4 |
0.92 |
- |
- |
- |
- |
- |
0.920 |
- |
- |
- |
- |
phosphatidylinositol specific phospholipase C X domain containing 2 [Source:HGNC Symbol;Acc:HGNC:26462] |
77. |
AP4S1 |
ENSGALG00000009936 |
55 |
0.92 |
- |
- |
- |
- |
- |
0.920 |
- |
- |
- |
- |
adaptor related protein complex 4 subunit sigma 1 [Source:HGNC Symbol;Acc:HGNC:575] |
78. |
NPDC1 |
ENSGALG00000042635 |
12 |
0.92 |
- |
- |
- |
- |
- |
0.920 |
- |
- |
- |
- |
neural proliferation, differentiation and control 1 [Source:HGNC Symbol;Acc:HGNC:7899] |
79. |
ENSGALG00000026671 |
ENSGALG00000026671 |
4 |
0.92 |
- |
- |
- |
- |
- |
0.920 |
- |
- |
- |
- |
|
80. |
VDHAP |
ENSGALG00000010417 |
9 |
0.919 |
- |
- |
- |
- |
- |
0.919 |
- |
- |
- |
- |
vitamin D3 hydroxylase associated protein [Source:NCBI gene;Acc:395824] |
81. |
TFCP2L1 |
ENSGALG00000011635 |
4 |
0.919 |
- |
- |
- |
- |
- |
0.919 |
- |
- |
- |
- |
transcription factor CP2 like 1 [Source:HGNC Symbol;Acc:HGNC:17925] |
82. |
TXK |
ENSGALG00000014127 |
6 |
0.919 |
- |
- |
- |
- |
- |
0.919 |
- |
- |
- |
- |
TXK tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:12434] |
83. |
TRIM42 |
ENSGALG00000005286 |
2 |
0.915 |
- |
- |
0.915 |
- |
- |
- |
- |
- |
- |
- |
tripartite motif containing 42 [Source:HGNC Symbol;Acc:HGNC:19014] |
84. |
SNORD21 |
SNORD21 |
2 |
0.915 |
- |
- |
0.915 |
- |
- |
- |
- |
- |
- |
- |
|
85. |
LMLN |
ENSGALG00000012067 |
15 |
0.914 |
- |
- |
- |
0.914 |
- |
- |
- |
- |
- |
- |
leishmanolysin like peptidase [Source:HGNC Symbol;Acc:HGNC:15991] |
86. |
SPINK7 |
SPINK7 |
254 |
0.891 |
- |
- |
- |
- |
- |
0.891 |
- |
- |
- |
- |
|
87. |
NKAIN4 |
ENSGALG00000005774 |
10 |
0.887 |
- |
- |
- |
0.887 |
- |
- |
- |
- |
- |
- |
sodium/potassium transporting ATPase interacting 4 [Source:HGNC Symbol;Acc:HGNC:16191] |
88. |
DNASE1L3 |
|
386 |
0.872 |
- |
- |
- |
- |
- |
0.872 |
- |
- |
- |
- |
deoxyribonuclease 1 like 3 |
89. |
ENSGALG00000023773 |
ENSGALG00000023773 |
77 |
0.867 |
- |
- |
- |
- |
- |
0.867 |
- |
- |
- |
- |
|
90. |
gga-mir-6569 |
ENSGALG00000026551 |
10 |
0.866 |
- |
- |
- |
- |
- |
0.866 |
- |
- |
- |
- |
gga-mir-6569 [Source:miRBase;Acc:MI0022387] |
91. |
RIBC2 |
ENSGALG00000014232 |
13 |
0.86 |
- |
- |
- |
0.860 |
- |
- |
- |
- |
- |
- |
RIB43A domain with coiled-coils 2 [Source:HGNC Symbol;Acc:HGNC:13241] |
92. |
SEC14L5 |
ENSGALG00000045758 |
25 |
0.859 |
- |
- |
- |
- |
- |
0.859 |
- |
- |
- |
- |
SEC14 like lipid binding 5 [Source:HGNC Symbol;Acc:HGNC:29032] |
93. |
PANK3 |
ENSGALG00000001895 |
11 |
0.855 |
- |
- |
0.855 |
- |
- |
- |
- |
- |
- |
- |
pantothenate kinase 3 [Source:HGNC Symbol;Acc:HGNC:19365] |
94. |
THSD7B |
ENSGALG00000012362 |
8 |
0.854 |
- |
- |
- |
0.854 |
- |
- |
- |
- |
- |
- |
thrombospondin type 1 domain containing 7B [Source:HGNC Symbol;Acc:HGNC:29348] |
95. |
SAPCD2 |
|
12 |
0.85 |
- |
- |
- |
- |
- |
0.850 |
- |
- |
- |
- |
suppressor APC domain containing 2, transcript variant X1 |
96. |
SYNDIG1 |
ENSGALG00000039587 |
922 |
0.846 |
- |
- |
- |
0.846 |
- |
- |
- |
- |
- |
- |
synapse differentiation inducing 1 [Source:HGNC Symbol;Acc:HGNC:15885] |
97. |
AAK1 |
ENSGALG00000041911 |
16 |
0.845 |
- |
- |
0.845 |
- |
- |
- |
- |
- |
- |
- |
AP2 associated kinase 1 [Source:HGNC Symbol;Acc:HGNC:19679] |
98. |
CALCA |
CALCA |
682 |
0.844 |
- |
- |
- |
0.844 |
- |
- |
- |
- |
- |
- |
|
99. |
TIMP4 |
ENSGALG00000004969 |
21 |
0.841 |
- |
- |
- |
0.841 |
- |
- |
- |
- |
- |
- |
TIMP metallopeptidase inhibitor 4 [Source:HGNC Symbol;Acc:HGNC:11823] |
100. |
ANTXRL |
ENSGALG00000005969 |
230 |
0.834 |
- |
- |
- |
- |
- |
0.834 |
- |
- |
- |
- |
anthrax toxin receptor-like |